194 related articles for article (PubMed ID: 31838220)
1. Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis.
Marchetti C; Fagotti A; Tombolini V; Scambia G; De Felice F
Cancer Treat Rev; 2020 Feb; 83():101945. PubMed ID: 31838220
[TBL] [Abstract][Full Text] [Related]
2. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
3. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis.
Zou W; Han Y; Zhang Y; Hu C; Feng Y; Zhang H; Wang J
PLoS One; 2019; 14(11):e0225264. PubMed ID: 31725793
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.
Xu Y; Zhang M; Zhang J; Ng DM; Chen X; Si Y; Shi Y; Li X; Mao D; Yang L
Taiwan J Obstet Gynecol; 2021 May; 60(3):433-441. PubMed ID: 33966724
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
Lee J; Kim TH; Kim GE; Keum KC; Kim YB
J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
9. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
[TBL] [Abstract][Full Text] [Related]
10. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
[No Abstract] [Full Text] [Related]
12. Long-Term Survival Rates and Prognostic Factors of Cervix Cancer Treated by Different Modalities.
Viani GA; Dos Santos FM; Pavoni JF
Am J Clin Oncol; 2020 Jan; 43(1):52-57. PubMed ID: 31764019
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery.
Sun H; Huang K; Tang F; Li X; Wang X; Long S; Zhou S; Suolangquzhen ; Zhang J; Ning R; Li S; Wang S; Ma D
Sci Rep; 2018 Apr; 8(1):6443. PubMed ID: 29691415
[TBL] [Abstract][Full Text] [Related]
16. Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study.
Zhao H; He Y; Zhu LR; Wang JL; Guo HY; Xu T; Wang YQ; Yao Y; Wu YM
Medicine (Baltimore); 2019 May; 98(21):e15604. PubMed ID: 31124937
[TBL] [Abstract][Full Text] [Related]
17. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
Ferrandina G; Palluzzi E; Gallotta V; Gambacorta MA; Autorino R; Turco LC; Macchia G; Cosentino F; Gui B; Mattoli MV; Ronzino G; Valentini V; Scambia G
Eur J Surg Oncol; 2018 Jul; 44(7):1062-1068. PubMed ID: 29753611
[TBL] [Abstract][Full Text] [Related]
18. Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
Kenter GG; Greggi S; Vergote I; Katsaros D; Kobierski J; van Doorn H; Landoni F; van der Velden J; Reed N; Coens C; van Luijk I; Colombo N; Steen-Banasik EV; Ottevanger N; Casado A;
J Clin Oncol; 2023 Nov; 41(32):5035-5043. PubMed ID: 37656948
[TBL] [Abstract][Full Text] [Related]
19. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
20. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Lee DW; Lee KH; Lee JW; Park ST; Park JS; Lee HN
Int J Gynecol Cancer; 2013 Sep; 23(7):1303-10. PubMed ID: 23881101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
